BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26061431)

  • 1. AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol.
    Chen S; Yin C; Lao T; Liang D; He D; Wang C; Sang N
    Cell Cycle; 2015 Aug; 14(15):2520-36. PubMed ID: 26061431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression.
    Peng D; Wu T; Wang J; Huang J; Zheng L; Wang P; Li J; Wu L; Luo M
    Chem Biol Interact; 2022 Mar; 355():109780. PubMed ID: 34990588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.
    Zhang D; Li J; Costa M; Gao J; Huang C
    Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1.
    Seo HW; Kim EJ; Na H; Lee MO
    FEBS Lett; 2009 Jan; 583(1):55-60. PubMed ID: 19071119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation.
    Jeong JH; Kang JH; Hwang SL; Cho HJ; Park KK; Park YY; Chung IK; Chang HW; Kim CH; Min KS; Kim HD; Magae J; Kang SS; Chang YC
    Biochem Biophys Res Commun; 2011 Mar; 406(3):353-8. PubMed ID: 21329651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
    Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
    Kong X; Lin Z; Liang D; Fath D; Sang N; Caro J
    Mol Cell Biol; 2006 Mar; 26(6):2019-28. PubMed ID: 16507982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
    Luo W; Zhong J; Chang R; Hu H; Pandey A; Semenza GL
    J Biol Chem; 2010 Feb; 285(6):3651-3663. PubMed ID: 19940151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tonicity enhancer binding protein (TonEBP) and hypoxia-inducible factor (HIF) coordinate heat shock protein 70 (Hsp70) expression in hypoxic nucleus pulposus cells: role of Hsp70 in HIF-1α degradation.
    Gogate SS; Fujita N; Skubutyte R; Shapiro IM; Risbud MV
    J Bone Miner Res; 2012 May; 27(5):1106-17. PubMed ID: 22322648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.
    Schilling D; Tetzlaff F; Konrad S; Li W; Multhoff G
    Cell Stress Chaperones; 2015 Jan; 20(1):139-47. PubMed ID: 25103413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electroacupuncture for myocardial ischemia injury in rats via AMPK-HDAC5-HIF-1α signaling].
    Lu S; Ding Y; Yu M; Fu S; Hong H; Zhu B
    Zhongguo Zhen Jiu; 2018 Sep; 38(9):978-83. PubMed ID: 30672184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis.
    Zhang Y; Ren YJ; Guo LC; Ji C; Hu J; Zhang HH; Xu QH; Zhu WD; Ming ZJ; Yuan YS; Ren X; Song J; Yang JM
    Oncogene; 2017 Jul; 36(29):4171-4181. PubMed ID: 28319066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 1 regulates reactive oxygen species-dependent degradation of histone deacetylase 5 by intermittent hypoxia.
    Wang N; Prabhakar NR; Nanduri J
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C423-C431. PubMed ID: 35704695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortalin-mediated and ERK-controlled targeting of HIF-1α to mitochondria confers resistance to apoptosis under hypoxia.
    Mylonis I; Kourti M; Samiotaki M; Panayotou G; Simos G
    J Cell Sci; 2017 Jan; 130(2):466-479. PubMed ID: 27909249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase mediates myogenin expression and myogenesis via histone deacetylase 5.
    Fu X; Zhao JX; Liang J; Zhu MJ; Foretz M; Viollet B; Du M
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C887-95. PubMed ID: 23926128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote Limb Ischemic Preconditioning Protects Rats Against Cerebral Ischemia via HIF-1α/AMPK/HSP70 Pathway.
    Xia M; Ding Q; Zhang Z; Feng Q
    Cell Mol Neurobiol; 2017 Aug; 37(6):1105-1114. PubMed ID: 27896629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α.
    Marin JJG; Lozano E; Perez MJ
    Free Radic Biol Med; 2016 Dec; 101():71-84. PubMed ID: 27687210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α-induced HSP70 regulates anabolic responses in articular chondrocytes under hypoxic conditions.
    Tsuchida S; Arai Y; Takahashi KA; Kishida T; Terauchi R; Honjo K; Nakagawa S; Inoue H; Ikoma K; Ueshima K; Matsuki T; Mazda O; Kubo T
    J Orthop Res; 2014 Aug; 32(8):975-80. PubMed ID: 24677016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α.
    Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G
    Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.